Health August 18, 2026

AI-powered drug dosing requires trust, integration, and innovation

Key Takeaways

  • Strengthen care with AI-driven, evidence-based drug dosing for safer clinical decisions.
  • Scale medication management with enterprise-wide access to trusted dosing guidance.
  • Complex dosing requires AI tools built on content authored and updated by a global network of practicing clinicians.
The right evidence-based AI-powered drug dosing tool needs to be built on trusted content and pharmacist expertise to help healthcare systems confidently scale medication intelligence across teams.

AI use in healthcare is rapidly rising, but the risks of uncoordinated adoption are becoming clearer. When clinical teams experiment with isolated, department-level tools, organizations face inconsistent recommendations, unclear governance, and avoidable security concerns. A patchwork approach to decision support tools can increase variation in care and strain IT resources.

To address these issues, health systems are moving toward a systemic, enterprise-first strategy. This means selecting AI partners who can support every part of the care journey—across all teams, sites, and roles—with evidence-based tools seamlessly embedded in day-to-day workflows. This drive toward efficiency and support for clinician confidence is what’s fueling the momentum behind UpToDate® Expert AI — now actively being implemented by leading organizations such as University of Iowa Health System, Sharp Healthcare, Duke University Health System, and Intermountain.

Accessing dosing information through UpToDate Expert AI is fast and reliable… The underlying assumptions built into the system and ability to change those as needed based on my query was also very helpful and saved me valuable time.
Vernon Rayford, MD, Internal Medicine, Pediatrics, North Mississippi Health Services

Identifying the right AI dosing tools for health systems

As AI is further integrated into health systems, medication prescribing and drug dosing decisions can be the most complex and risk-prone if guidance is incorrect. Medication-related harm impacts 1 out of 30 patients and accounts for half of all avoidable harm in healthcare. Additionally, older patients and those with comorbidities often face polypharmacy management, and the slightest dosing error can introduce risk to care.

Clinicians are already using AI tools for medication decisions. The Wolters Kluwer 2026 Future Ready Healthcare Report found 41% of physicians and 37% of nurses report using AI to check diagnoses or drug interactions. However, the same report found 77% of physicians rated “potential hallucinations” from AI tools as a high-impact risk—a challenge for nuanced scenarios like edge cases, rare disease, and atypical dosing that make it hard for the health systems to fully trust AI tools.

UpToDate® Expert AI has been developed to support complex care scenarios and to clearly identify when there isn’t enough evidence to support a recommendation. With the addition of drug dosing guidance for US users, supported by drug referential content from UpToDate® Lexidrug™, clinicians can ask dosing questions with confidence that the responses will be supported by evidence-based recommendations authored and regularly updated by thousands of practicing clinicians and pharmacists.

With enterprise-wide access to drug dosing, healthcare leaders can help:

  • Strengthen and scale decision support through access to governed medication intelligence.
  • Advance medication safety and quality goals with more consistent dosing insights across teams.
  • Support responsible AI adoption with transparent, clinically grounded dosing recommendations.
Chris Madjerich discusses drug dosing complexity.
Chris Madjerich discusses the complexity of drug dosing and the limitations of AI.

How does ongoing innovation help meet real-world clinical needs?

Today’s solution partners need to keep pace with evolving clinical demands. UpToDate’s approach combines continuous product innovation with direct input from clinician users, so features and tools are highly relevant for the clinical workflow.

Recent innovations in UpToDate Expert AI reflect this commitment:

  • CME integration: Clinicians can earn education credits while seeking answers during care, supporting both professional development and adoption across the enterprise.
  • Enhanced differential diagnosis: Clinicians can navigate complex cases with greater clarity and confidence, critical for reducing diagnostic errors and improving patient outcomes.
  • Mobile access: An AI-native mobile app provides access to decision support wherever clinicians work, enhancing usability and consistency even in high-pressure settings.
  • Secure PHI and PII data minimization: Strengthened privacy protections to update how Protected Health Information (PHI) and Personally Identifiable Information (PII) are detected and removed when included in a prompt.
  • Drug dosing guidance: Integrating drug insights from UpToDate Lexidrug into UpToDate Expert AI to support complex dosing, contraindications, and interactions.

This innovation is ongoing, and feedback from health systems directly helps inform the product roadmap. This practical and collaborative partnership helps ensure innovations solve the operational and clinical challenges that matter most—especially medication management and dosing decisions.

Health systems are no longer looking for temporary AI pilots or technology experiments. The priority is to select a partner that is ready to scale, can integrate into existing EHRs, is deeply grounded in clinical realities, and is committed to collaborating for a better healthcare future.

Learn more about integrating AI-powered drug dosing intelligence across your health system with UpToDate® Enterprise Edition, now available for US customers.

Learn About Drug Dosing
Connect With The UpToDate Team
Back To Top